gsk product pipeline tjw dank, page-3

Hi all, I found some more information, which makes me think this is IV Relenza, if you take the same link....................

http://www.gsk.com/investors/pp_pipeline_standard.htm

And find under Anti-Virals Relenza, it was submitted on the same date under heading (MAA) and (NDA) First EU Approval letter.

Also if you scroll down to the bottom of the page there is a statement.............

For competitive reason, new projects in pre-clinical development have not been disclosed and some project types may not have been identified.

There is more for you to read.................

Also Relenza and Flu pandemic were submitted on DEC 05, so that is another link.

I would be interested if someone, with Science background to have a look at.........FLU PANDEMIC - Inactivated whole-aluminium salt adjuvant.............does this added compound make Relenza into Intravenous form...........That is IV Relenza?

Does Biota know about this, I think they do are unable to say at present.

This is getting very exciting folks
Cheers all, DMA